Deep learning is effective for the classification of OCT images of
  normal versus Age-related Macular Degeneration by Lee, Cecilia S. et al.
Deep learning is effective for the classification of OCT images of normal versus 
Age-related Macular Degeneration  
 
Cecilia S. Lee MD1, Doug M. Baughman BS1, Aaron Y. Lee MD MSCI1 
1 Department of Ophthalmology 
University of Washington School of Medicine, Seattle WA 
Corresponding Author: 
Aaron Y. Lee 
Assistant Professor  
Department of Ophthalmology  
University of Washington 
Box 359608, 325 Ninth Avenue 
Seattle WA 98104 
Ph: (206) 543-7250 
Email: leeay@uw.edu 
 
 
Financial support: National Eye Institute, Bethesda, Maryland (grant no.: K23EY02492 
[C.S.L.]); Latham Vision Science Innovation Grant, Seattle WA (C.S.L., D.M.B.)  and 
Research to Prevent Blindness, Inc., New York, New York (C.S.L., A.Y.L.).  The 
sponsors and funding organizations had no role in the design or conduct of this 
research. 
 
Conflict of interest: No conflicting relationship exists for any author. 
 
Running head: Deep learning for classification of macular OCT images 
 
Abbreviations and acronyms 
AMD: Age-related Macular Degeneration 
AUROC: Area Under the Receiver Operator Curve 
CAD: Computer Aided Diagnosis 
EMR: Electronic Medical Records 
FDA: Food and Drug Administration 
GPU: Graphics Processing Unit 
ICD-9: International Classification of Diseases, 9th edition 
OCT: Optical Coherence Tomography 
ReLU: Rectified Linear Unit 
ROC: Receiver Operator Curve  
RPE: Retinal Pigmented Epithelium 
SD: Standard Deviation 
UW: University of Washington 
 
	
	
ABSTRACT	
Objective:  The advent of Electronic Medical Records (EMR) with large electronic imaging 
databases along with advances in deep neural networks with machine learning has provided a 
unique opportunity to achieve milestones in automated image analysis. Optical coherence 
tomography (OCT) is the most commonly obtained imaging modality in ophthalmology and 
represents a dense and rich dataset when combined with labels derived from the EMR. We 
sought to determine if deep learning could be utilized to distinguish normal OCT images from 
images from patients with Age-related Macular Degeneration (AMD).	
	
Design: EMR and OCT database study	
	
Subjects: Normal and AMD patients who had a macular OCT.	
	
Methods: Automated extraction of an OCT imaging database was performed and linked to 
clinical endpoints from the EMR. OCT macula scans were obtained by Heidelberg Spectralis, 
and each OCT scan was linked to EMR clinical endpoints extracted from EPIC. The central 11 
images were selected from each OCT scan of two cohorts of patients: normal and AMD. Cross-
validation was performed using a random subset of patients. Receiver operator curves (ROC) 
were constructed at an independent image level, macular OCT level, and patient level. 	
	
Main outcome measure: Area under the ROC.	
	
Results: Of a recent extraction of 2.6 million OCT images linked to clinical datapoints from the 
EMR, 52,690 normal macular OCT images and 48,312 AMD macular OCT images were 
selected. A deep neural network was trained to categorize images as either normal or AMD. At 
the image level, we achieved an area under the ROC of 92.78% with an accuracy of 87.63%. At 
the macula level, we achieved an area under the ROC of 93.83% with an accuracy of 88.98%. 
At a patient level, we achieved an area under the ROC of 97.45% with an accuracy of 93.45%. 
Peak sensitivity and specificity with optimal cutoffs were 92.64% and 93.69% respectively.	
	
Conclusions: Deep learning techniques achieve high accuracy and is effective as a new image 
classification technique. These findings have important implications in utilizing OCT in 
automated screening and the development of computer aided diagnosis tools in the future.	
	
	 	
INTRODUCTION	
	
Optical coherence tomography (OCT) has become the most commonly used imaging modality 
in ophthalmology with 4.39 million, 4.93 million, and 5.35 million OCTs performed in 2012, 2013, 
and 2014 respectively in the US Medicare population.1 Since its development in 1991,2 a 70-fold 
increase in OCT use for diagnosing age-related macular degeneration (AMD) was reported 
between 2002 and 2009.3 Furthermore, since the development of anti-angiogenic agents, OCT 
has become a critical tool for baseline retinal evaluation prior to initiation of therapy and 
monitoring therapeutic effect.4,5 This increase in the use of OCT imaging, with images stored in 
large electronic databases, highlights the ever-increasing time and effort spent by providers 
interpreting images.	
	
The key OCT findings in AMD, including drusen, retinal pigmented epithelium (RPE) changes, 
and subretinal and intraretinal fluid,4 share some common OCT features that are distinctively 
different from a normal retina.6 Correct identification of these characteristics allows for precise 
management of neovascular AMD and guides the decision of whether intravitreal therapy with 
anti-VEGF agents should be given or not.7–9  Computer aided diagnosis (CAD) has the potential 
for allowing more efficient identification of pathological OCT images and directing the attention 
of the clinician to regions of interest on the OCT images. 	
	
The concept of CAD is not novel and has been applied in radiology, a field where the increasing 
demand of imaging studies has begun to outpace the capacity of practicing radiologists.10 A 
number of CAD systems have been approved by the Food and Drug Administration (FDA) for 
lesion detection and volumetric analysis in mammography, chest radiography, and chest 
computed tomography.11	
	
Traditional image analysis required the manual development of convolutional matrices applied 
to an image for edge detection and feature extraction. In addition, prior work on OCT image 
classification of diseases has relied on machine learning techniques such as Principal 
Components Analysis, Support Vector Machine, or Random Forest.12–14 However recently, there 
has been a revolutionary step forward in machine learning techniques with the advent of deep 
learning where a many-layered neural network is trained to develop these convolutional 
matrices purely from training data.15 Specifically, the development of convolutional neural 
network layers allowed for significant gains in the ability to classify images and detect objects in 
a picture.16–18 Within ophthalmology, deep learning has been recently applied at a limited 
capacity  to automated detection of diabetic retinopathy from fundus photos, visual field 
perimetry in glaucoma patients, grading of nuclear cataracts, and segmentation of foveal 
microvasculature, each with promising initial findings.19–22	
	
While deep learning has revolutionized the field of computer vision, their application is usually 
limited due to the lack of large training sets. Often several tens of thousands of examples are 
required before deep learning can be used effectively. With the ever increasing use of OCT as 
an imaging modality in ophthalmology along with the use of codified structured clinical data in 
the Electronic Medical Record (EMR), we sought to link two large datasets together to use as a 
training set for developing a deep learning algorithm to distinguish AMD from normal OCT 
images. 	
	
METHODS	
	
This study was approved by the Institutional Review Board of the University of Washington 
(UW) and was in adherence with the tenets of the Declaration of Helsinki and the Health 
Insurance Portability and Accountability Act. 	
	
OCT and EMR Extraction	
Macular OCT scan were extracted using an automated extraction tool from the Heidelberg 
Spectralis imaging database from 2006 to 2016. Each macular scan was obtained using a 61 
line raster macula scan, and every image of each macular OCT was extracted. The images 
were then linked by patient medical record number and dates to the clinical data stored in EPIC. 
Specifically, all clinical diagnoses and the dates of every clinical encounter, macular laser 
procedures, and intravitreal injections were extracted from the EPIC Clarity tables. 	
	
Patient and Image Selection	
A normal patient was defined as having no retinal ICD-9 diagnosis and better than 20/30 vision 
in both eyes during the entirety of recorded clinical history at UW. An AMD patient was defined 
as having the ICD-9 diagnosis of AMD (362.50, 362.51, and 362.52) by a retina specialist, at 
least one intravitreal injection in either eye, and worse than 20/30 vision in the better seeing 
eye. Patients with other macular pathology by ICD-9 code were excluded. These parameters 
were chosen a priori to ensure that macular pathology was most likely present in both eyes in 
the AMD patients and absent in both eyes in the normal patients. Consecutive images of 
patients meeting this criteria were included and no images were excluded due to image quality. 
Labels from the EMR were then linked to the OCT macular images, and the data was stripped 
of all protected health identifiers.	
	
As most of the macular pathology is concentrated in foveal region, the decision was made a 
priori to select the central 11 images from each macular OCT set, and each image was then 
treated independently, labeled as either normal or AMD. The images were histogram equalized 
and the resolution down-sampled to 192x124 due to limitations of memory. The image set was 
then divided into two sets with 20% of the patients in each group placed into the validation set 
and the rest were used for training. Care was taken to ensure that the validation set and the 
training set contained images from mutually exclusive group of patients (i.e. no single patient 
contributed images to both the training and validation set). The order of images was then 
randomized in the training set. 	
	
Deep Learning Classification Model	
A modified version of the VGG16 convolutional neural network23 was used as the deep learning 
model for classification (Figure 1). Weights were initialized using the Xavier algorithm.24 Training 
was then performed using multiple iterations each with a batch size of 100 images with a 
starting learning rate of 0.001 with stochastic gradient descent optimization. At each iteration, 
the loss of the model was recorded, and at every 500 iterations, the performance of the neural 
network was assessed using cross-validation with the validation set. The training was stopped 
when the loss of the model decreased and the accuracy of the validation set decreased. 	
	
An occlusion test17 was performed to identify the areas most contributing to the neural network 
assigning the category of AMD. A blank 20x20 pixel box was systematically moved across every 
possible position in the image and the probabilities were recorded. The highest drop in the 
probability represents the region of interest that contributed the highest importance to the deep 
learning algorithm.	
	
Caffe (http://caffe.berkeleyvision.org/) and Python (http://www.python.org) were used to perform 
deep learning. All training occurred using the NVIDIA Pascal Titan X Graphics Processing Unit 
(GPU) with NVIDA cuda (v8.0) and cu-dnn (v5.5.1) libraries (http://www.nvidia.com). Macular 
OCT level analysis was performed by averaging the probabilities of the images obtained from 
the same macular OCT. Patient level analysis was performed by averaging the probabilities of 
the images obtained from the same patient. Receiver-operator curves (ROC) were constructed 
using the probability output from the deep learning model. Statistics were performed using R 
(http://www.r-project.org). 	
	
RESULTS	
	
We successfully extracted 2.6 million OCT images of 43,328 macular OCT scans from 9,285 
patients. After linking the macular OCT scans to the EMR, 48,312 images from 4,392 normal 
OCT scans and 52,690 images from 4,790 AMD OCT scans were selected. A total of 80,839 
images (41,074 from AMD, 39,765 from normal) were used for training and 20,163 images 
(11,616 from AMD, 8,547 from normal) were used for validation. 	
	
After 8,000 iterations of training the deep learning model, the training was stopped due to 
overfitting occurring after that point.(Figure 2) ROC curves are shown at the image level, OCT 
macular level, and the patient level in Figure 3. The average time to evaluate a single image 
after training was complete was 4.97 milliseconds. 	
	
At the level of each individual image, we achieved an accuracy of 87.63% with a sensitivity of 
84.63% and a specificity of 91.54%. After constructing an ROC curve, the peak sensitivity and 
specificity with optimal cutoffs were 87.08% and 87.05% respectively. The area under the ROC 
curve (AUROC) was 92.77%. 	
	
By grouping the images in the same OCT scan and averaging the probabilities from each 
image, we achieved an accuracy of 88.98% with a sensitivity of 85.41% and a specificity of 
93.82%. After constructing the ROC curve, the peak sensitivity and specificity with optimal 
cutoffs were 88.63% and 87.77%. The AUROC was 93.82%.	
	
By averaging the probabilities from each image from the same patient, we achieved an 
accuracy of 93.45% with a sensitivity of 83.82% and a specificity of 96.40%. After constructing 
the ROC curve, the peak sensitivity and specificity with optimal cutoffs were 92.64% and 
93.69%. The AUROC was 97.46%.	
	
Example images from the occlusion test are shown in Figure 4 showing that the neural network 
was successfully able to identify pathological regions on the OCT. These areas represent the 
most critical area in each image to the trained network in categorizing the image as AMD. 	
	
DISCUSSION	
	
The ever increasing use of digital imaging and EMRs provide opportunities to create deep and 
rich datasets for analysis. Our study demonstrates that a deep learning neural network was 
effective at distinguishing AMD from normal OCT images, and its accuracy was even higher 
when aggregate probabilities at the OCT macular scan and patient level were combined. The 
increase in the AUROC mainly occurred with an increase in the sensitivity (Figure 3) with 
inclusion of more images when aggregated. This most likely occurred as AMD infrequently 
affects the entire macula and normal appearing OCT images may be mixed in with a macular 
OCT scan obtained from an AMD patient. Another possible explanation is that the etiology of 
the CNVM may be incorrect in the EMR. For example, our AMD labeled images may have 
included myopic CNVM which has localized pathology with relatively normal OCTs outside the 
CNVM area. Thus, adding additional images may explain the increased sensitivity. 	
	
Only limited applications of deep learning models exist in ophthalmology. Abramoff et al. 
reported sensitivity of 96.8% and specificity of 87.0% in detecting referable diabetic retinopathy 
in 874 patients using deep learning model, but no details of the algorithm were included.20 
Asaoka et al. used a deep learning method to differentiate the visual fields of 27 patients with 
preperimetric open angle glaucoma from 65 controls.19 The AUROC of 92.6% was achieved 
with this study’s feed-forward network classifier, but the algorithm only used four layers of 
neurons. In contrast, our study deep learning algorithm included 21 layers of neurons with state 
of the art convolutional neural networking layers. Other smaller studies that have applied 
automated OCT classification algorithms did not integrate deep learning strategies and was 
limited by small sample size ranging from 32 to 384.12,19,20	
 	
Our deep learning algorithm is a novel application to OCT classification in ophthalmology. To 
our best knowledge, the use of training and validation images from large EMR extraction has 
never been shown. In order to verify how the deep learning algorithm categorized the images as 
AMD, we performed an occlusion test where we systematically occluded every location in the 
image with a blank 20x20 pixel area.  The deep learning neural network successfully identified 
key areas of interest on the OCT image, which corresponded to the areas of pathology (Figure 
4).  
 
The application of occlusion testing provides insight into the trained deep learning model and 
which features were most important in distinguishing AMD images from normal images. In 
Figure 4C, occlusion testing did not show high intensity dependence in the area of nasal high 
choroidal transmission suggesting that the classifier was not using this as an important feature. 
One possible explanation is that in distinguishing normal from AMD OCT images, the classifier 
already achieved very low loss (Figure 2B) using the identified features and never discovered 
further improvements. Further studies could be performed where a classifier is specifically 
trained to distinguish specific AMD OCT features such as drusen, subretinal fluid, pigment 
epithelial detachments, and high choroidal transmission from each other. 	
	
Our study findings have several limitations. We only included images from patients who met our 
study criteria and the neural network was only trained on these images. However, we included 
consecutive real-world images and did not exclude images with poor quality. In addition, the 
training of this model was only done on images from a single academic center and the external 
generalizability is unknown. Future studies would include expanding the number of diagnoses, 
using all images from a macular OCT scan, including images from different OCT manufacturers, 
and validation on OCT scans from other institutions.	
	
In the future, our approach may be used to develop deep learning models that can have a 
number of wide-reaching applications. First, the models can be applied to various retinal or 
choroidal pathologies in which OCT evaluations are essential, including diabetic retinopathy or 
retinal vein occlusions. Second, in future studies using deep learning, automated macular OCT 
classification could be used as a screening tool for retinal pathology when the hardware cost of 
OCT machines decreases. This automated classification could be added to the majority of OCT 
machines being used in clinical practice without the need of integrating GPU as the inference 
step of deep learning is computationally inexpensive compared to training and can be run on 
standard computers. The automated classification feature will likely be beneficial in a large 
screening model such as in an AMD screening system. Finally, deep learning models can 
identify concerning macular OCT images and efficiently display them to the clinician to aid in the 
diagnosis and treatment of macular pathology, much like computer-aided diagnosis models 
found in radiology. 	
	
In conclusion, we demonstrate the ability of a deep learning model to distinguish AMD versus 
normal OCT images and show encouraging results for the first application of deep learning to 
OCT images. Future follow up studies will include widening the number of diseases and 
showing external validity of the model using images from other institutions. 	
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	FIGURE LEGENDS	
	
FIGURE 1: Schematic of the deep learning model used. A total of 21 layers with Rectified Linear 
Unit (ReLU) activations were used. 	
	
FIGURE 2: Learning curve of the training of the neural network with accuracy (A) and loss (B). 
Each iteration represents 100 images being trained on the neural network. 	
	
FIGURE 3: Receiver-operator curves of three levels of classification. Image level classification 
was performed by considering each image independently. Macula level classification was 
performed by averaging the probabilities of all the images in a single macular volume. Patient 
level classification was performed by averaging the probabilities of all the images belonging to a 
single patient. 	
	
FIGURE 4: Examples of identification of pathology by deep learning algorithm. Images of optical 
coherence tomography (OCT) with age-related macular degeneration (AMD) pathology (A, B, C) 
are used as input images and hotspots (D, E, F) are identified using an occlusion test from the 
deep learning algorithm. The intensity of the color is determined by the drop in the probability of 
being labeled AMD when occluded. 	
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